{
    "clinical_study": {
        "@rank": "104157", 
        "arm_group": [
            {
                "arm_group_label": "Beractant", 
                "arm_group_type": "Active Comparator", 
                "description": "Beractant;bovine lung extract; both initial and subsequent dosing is 100 mg/kg (4 mL/kg), which may be given every 6 hours up to four total doses"
            }, 
            {
                "arm_group_label": "Poractant alfa", 
                "arm_group_type": "Active Comparator", 
                "description": "Poractant alfa; porcine lung extract; initial dosing is 200 mg/kg (2.5 mL/kg) and repeated dosing is given at 100 mg/kg (1.25 mL/kg) every 12 hours, up to maximum of two additional doses when indicated"
            }
        ], 
        "brief_summary": {
            "textblock": "Perfusion index may vary according to type of surfactant during the treatment of respiratory\n      distress syndrome."
        }, 
        "brief_title": "Perfusion Index Variability in Respiratory Distress Syndrome", 
        "completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "condition": "Poor Peripheral Perfusion", 
        "condition_browse": {
            "mesh_term": [
                "Respiratory Distress Syndrome, Newborn", 
                "Respiratory Distress Syndrome, Adult"
            ]
        }, 
        "detailed_description": {
            "textblock": "Peripheral tissues of preterm infants are very sensitive for hypoperfusion, but there are\n      rare data in the literature for peripheral perfusion after surfactant treatment. In this\n      study the investigators aimed to compare the perfusion index (PI) variability in premature\n      infants with respiratory distress (RDS) following instillation of one of two different\n      natural surfactant preparations."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  premature infants < 32 weeks of gestational age\n\n        Exclusion Criteria:\n\n          -  congenital malformation\n\n          -  Apgar scores <3 at 5 min"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "3 Days", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "92", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01852461", 
            "org_study_id": "685.114A", 
            "secondary_id": "Surfactant trial"
        }, 
        "intervention": [
            {
                "arm_group_label": "Beractant", 
                "description": "Beractant;both initial and subsequent dosing is 100 mg/kg (4 mL/kg), which may be given every 6 hours up to four total doses", 
                "intervention_name": "Beractant", 
                "intervention_type": "Drug", 
                "other_name": "Beractant (Survanta)"
            }, 
            {
                "arm_group_label": "Poractant alfa", 
                "description": "porcine lung extract, initial dosing is 200 mg/kg (2.5 mL/kg) and repeated dosing is given at 100 mg/kg (1.25 mL/kg) every 12 hours, up to maximum of two additional doses when indicated", 
                "intervention_name": "Poractant alfa", 
                "intervention_type": "Drug", 
                "other_name": "Poractant alfa (curosurf)"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Beractant", 
                "Poractant alfa"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "natural surfactants; perfusion index", 
        "lastchanged_date": "May 10, 2013", 
        "number_of_arms": "2", 
        "official_title": "Perfusion Index Variability in Preterm Infants Treated With Two Different Natural Surfactants for Respiratory Distress Syndrome", 
        "other_outcome": {
            "description": "The effects of the two treatment regimens on mortality were compared", 
            "measure": "Mortality", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "overall_official": {
            "affiliation": "Sami Ulus CH", 
            "last_name": "Dilek Dilli, Assoc Prof", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Turkey: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "PI and oxygen saturation (SpO2) were measured by \"Masimo Rainbow SET Radical-7 pulse oximeter\" before and after surfactant. The effects of the two treatment regimens on PI, oxygenation and clinical outcome were compared.", 
            "measure": "perfusion index", 
            "safety_issue": "No", 
            "time_frame": "1 week"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01852461"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Dr. Sami Ulus Children's Hospital", 
            "investigator_full_name": "Dilek Dilli", 
            "investigator_title": "Assos Prof", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "The effects of the two treatment regimens on duration of mechanical ventilation were compared", 
            "measure": "Duration of mechanical ventilation", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "source": "Dr. Sami Ulus Children's Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Dr. Sami Ulus Children's Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}